Product
Imiglucerase
1 clinical trial
2 indications
Indication
Gaucher's Disease Type IIndication
Gaucher's Disease Type IIIClinical trial
Open Label, Two Cohort (With and Without Imiglucerase), Multicenter Study to Evaluate Pharmacokinetics, Safety, and Efficacy of Eliglustat in Pediatric Patients With Gaucher Disease Type 1 and Type 3Status: Active (not recruiting), Estimated PCD: 2025-11-20